Review was performed of extracapsular cataract extrac tion with posterior chamber lens implantation in 90 dia betic patients and 263 non-diabetic patients . There was a higher incidence of posterior capsular opacification as 
Preservation of the posterior capsule during extracapsular cataract extraction retains an avascular membrane between the vitreous cavity and the anterior chamber of the eye. Maintenance of the integrity of the posterior cap sule and anterior hyaloid face reduces the risk of retinal detachment I and pseudophakic macular oedema, " and is the major advantage of extracapsular over intracapsular cataract extraction. However, posterior capsule opacifica tion is a frequent cause of visual impairment following extracapsular cataract surgery. This is an important com plication in diabetics, in whom adequate fundus visual isation must be maintained because post-operative deterioration of retinopathy is likely.
Posterior capsular opacification is an age-related phenomenon and its incidence approaches 100% in paed iatric cases. 3 . 4 In the normal adult population the incidence is reported to the between 30% and 50% at 5 years. ),e, Fac tors believed to predispose to posterior capsular opac- x Factors thought to reduce the incidence include a wide anterior capsulectomy 9 and a posteriorly convex posterior chamber intraocular lens which is in close apposition to the posterior capsule and prevents migration of lens epi thelial cells across the visual axis. Cataract occurs at a younger age, 1O and post -operati ve inflammation is typically more severe, II -14 in diabetics than in non-diabetics, suggesting that the incidence of posterior capsule opacification might be higher in dia betics, although a higher incidence in non-diabetics than diabetics has been reported. I) To investigate this further we reviewed our experience of posterior capsular opac ification following diabetic cataract extraction.
METHOD
A retrospective review was performed of all diabetic and non-diabetic patients who underwent extracapsular catar act extraction and posterior chamber lens implantation during a 12 month period in 1990-1. Patients were excluded who had (I) a history of uveitis, (2) other proliferative retinopathy such as ischaemic central retinal vein occlusion, (3) coexisting retinal disease such as age related macular degeneration, (4) major operative compli cations such as vitreous loss, or (5) advanced diabetic eye disease including active proliferative diabetic retinopathy, iris neovascularisation and traction retinal detachment.
Pre-operative retinopathy severity was classified, as close to surgery as cataract allowed, into one of three groups: (I) no diabetic retinopathy, (2) non-proliferative diabetic retinopathy or (3) quiescent proliferative retino pathy defined as retinal neovascularisation managed by panretinal photocoagulation which had regressed with no further neovascularisation at 6 months follow-up.
Operations were performed by one consultant (A.M.H.) or experienced residents attached to this service. A corneal section was performed in the majority of cases. 'Can opener' anterior capsulotomy preceded expression of the nucleus with two-point pressure at 6 and 12 0' clock. Soft lens matter was aspirated with a coaxial cannula and a pos terior chamber lens inserted under a viscous agent. The section was closed using interrupted 10.0 monofilament nylon sutures.
Patients were reviewed on the first post-operative day, at 2 weeks, at 10 weeks and at intervals up to a mean fol low-up of 15 months (range 3-48 months). The presence of post-operative complications including uveitis, raised intraocular pressure, pigment dispersion and posterior synechiae was noted. If posterior capsular opacification was sufficient to cause reduced visual acuity or to impair adequate visualisation of the fundus, it was recorded and Nd:YAG capsulotomy was performed. All pre-operative and post-operative assessments were performed at Moor fields Eye Hospital and documentation was considered to be of good quality.
The incidence of posterior caps ulotomy was modelled using Kaplan-Meier survival analysis to allow for varia tion in follow-up between groups. The survival of differ ent groups was compared using the Mantel-Haenszel test. Cox's proportional hazards regression was used to com pare survival in different groups controlling for covar iates. The Wilcoxon rank sum test was used to compare medians in unpaired samples.
RESULTS
Ninety diabetic and 263 uncomplicated extracapsular cat aract extractions with posterior chamber lens implantation were included in the study. Median age at surgery was 69 years in diabetics and 74 years in non-diabetics (Wilcoxon rank sum p <0.05). Capsulotomy was undertaken in 48 of 263 (18%) non-diabetics, 5 of 37 (14%) diabetics without retinopathy, 12 of 35 (34%) diabetics with non-prolifer ative retinopathy, and 8 of 18 (44%) diabetics with quies cent proliferative retinopathy.
There was a higher incidence of posterior capsular opacification as judged by the requirement of Nd:Y AG capsulotomy in diabetics with non-proliferative (12/35, 34%) or quiescent proliferative diabetic retinopathy (8/18, 44%) than in non-diabetics (18%) (Mantel-Haenszel p = 0.04; Fig. 1 ). Subgroup analysis showed a higher 
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incidence of capsular opacification in diabetics with non proliferative (12/35, 34%) or quiescent proliferative retinopathy (8/18, 44%) than in diabetics without retino pathy (5/37,14%), but this was not statistically significant (Mantel-Haenszel p = 0.19 and p = 0.07, respectively; Fig. 2 ). There was no overall difference in the incidence of capsular opacification between diabetics (25/90, 28%) and non-diabetics (48/263, 18%) (Mante1-Haenszel p = 0.32).
Differences in the incidence of capsular opacification between groups were not explained by age when tested using Cox's proportional hazards modelling. No signifi cant relationship between intraoperative and post-oper ative complications and posterior capsular opacification was identified.
DISCUSSION
This retrospective review reports a higher incidence of posterior capsule opacification in patients with either non proliferative or quiescent proliferative diabetic retino pathy than in non-diabetics (Mantel-Haenszel p = 0.04). Despite the slightly younger age of diabetic patients, Cox modelling did not identify age as a confounding factor in the detection of these differences. There are three possible explanations for the higher incidence of posterior capsular opacification in diabetic patients with retinopathy. Firstly, cataract surgery may be more complicated (e.g. the requirement for sphincterotomy), and secondly post-oper ative complications (e.g. persistent uveitis) are commoner in the diabetic than the non-diabetic eye. No relationship between capsular opacification and postoperative uveitis was, however, identified. A third possible explanation is that proliferation of lens epithelial cells may be promoted by forward diffusion of growth factors from ischaemic retina. Iris neovascularisation develops more commonly following intracapsular than extracapsular cataract extrac tion in diabetics, If> because the posterior capsule acts as a partial barrier to the forward diffusion of growth factors. Growth factors may therefore accumulate at the posterior capsule and promote migration, proliferation and differ entiation of residual lens epithelial cells. The higher inci dence of posterior capsular opacification in the quiescent proliferative retinopathy group, in which significant ret inal ischaemia and therefore growth factors are present, is in accord with this hypothesis. 
CAPSULAR OPACIFICATION IN DIABETICS
The incidence of posterior capsular opacification in dia betics and non-diabetics has previously been reported as 28% and 33% respectively in a retrospective review of 939 eyes including 202 diabetics followed for a mean of 26 months. The lower incidence of posterior capsular opac ification was explained by reduced lens epithelial cell pro liferation due to intracellular accumulation of sorbitol. These findings are in contrast to the results of this study and may be explained by the different statistical method employed. In this study, Kaplan-Meier survival analysis was used to allow for variation in follow-up. It is recog nised that diabetic patients may have undergone posterior caps ulotomy with less opacification than non-diabetics in order to maintain fundus visualisation. Conversely, dia betics with maculopathy may not be aware of visual loss due to capsular opacification, suggesting that the inci dence of capsular opacification might be higher than reported. A prospective trial of the incidence of posterior capsule opacification is required to address this.
The practical implications of this study are that pos terior capsule opacification is a common occurrence after extracapsular cataract surgery in all patients, but is more common in diabetics with non-proliferative or quiescent proliferative retinopathy. It is therefore important to keep these patients under careful review so that a large posterior capsulotomy can be performed with Nd:Y AG laser at the earliest opportunity to maintain adequate fundus visual isation and assessment of diabetic retinopathy, which is particularly likely to deteriorate after cataract extraction. Early posterior caps ulotomy is important in patients with pre-existing retinopathy, since they are at the greatest risk of both posterior capsule opacification and post-operative deterioration of retinopathy.
